MedTrace Logo

Metabolic Syndrome and Fall Risk

NCT02633891 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2024-06-28

Study results available
· View outcomes & findings →

Summary

Obesity and the metabolic syndrome (MetS) are rapidly growing problems. Individuals with the MetS are at risk for not only future chronic diseases, but they have a higher prevalence of neuropathy, including cardiac autonomic neuropathy, and have a higher incidence of falls. Currently there are no effective therapies to prevent or reverse the neuropathy seen in the MetS or to reduced the fall risk in this population. This research project will determine if a tailored balance exercise program will have functional benefits and result in a reduced fall risk in the growing population of patients with the MetS and neuropathy.

Conditions

  • Metabolic Syndrome
  • Autonomic Neuropathy

Interventions

BEHAVIORAL

Balance exercise

tailored balance exercise program

BEHAVIORAL

Standard care

general health education and fall prevention classes

Sponsors & Collaborators

  • University of Maryland

    collaborator OTHER

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Lindsay A Zilliox, MD · Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-02
Primary Completion
2022-03-28
Completion
2022-03-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02633891 on ClinicalTrials.gov